Enanta Pharmaceuticals
ENTA
ENTA
181 hedge funds and large institutions have $1.19B invested in Enanta Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+33
Holders Change %
+22.3%
% of All Funds
4.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
51
Increased
59
Reduced
51
Closed
16
Calls
$4.23M
Puts
$1.21M
Net Calls
+$3.02M
Net Calls Change
+$1.04M
Top Buyers
Top Sellers
| 1 |
First Manhattan
New York
|
$70.5M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$0 |
| 3 |
Millennium Management
New York
|
$7.31M |
| 4 |
KAM
Krensavage Asset Management
New York
|
$59.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
$38.3M |
